Different responses of fluvastatin to cholesterol‐induced oxidative modifications in rabbits: evidence for preventive effect against DNA damage

Hypercholesterolemia is a major risk factor for atherosclerosis and related occlusive vascular diseases. We investigated the effect of low‐dose fluvastatin (2 mg kg−1 day−1) on antioxidant enzyme activities [superoxide dismutase (SOD), catalase], vascular reactivity changes and oxidatively induced DNA damage in early stage of atherosclerosis in hypercholesterolemic rabbits. The animals were divided into three groups each composed of 10 rabbits. The control group received a regular rabbit chow diet, and the cholesterol group had hypercholesterolemic diet (2%, 4 weeks). The fluvastatin group was given hypercholesterolemic diet plus fluvastatin. Dietary intake of cholesterol significantly increased total cholesterol levels in rabbits (control, 0.85 ± 0.29; cholesterol, 12.04 ± 4.61; fluvastatin, 8.07 ± 2.72 mmol l−1 ). Hypercholesterolemic diet revealed discernible fatty streaks in arcus aortae. Fluvastatin significantly reduced the areas of the lesions. The diet significantly increased SOD activities in both erythrocyte and tissue. Treatment with fluvastatin normalized the increased activity of SOD in both erythrocyte and aortic tissues from the cholesterol group. Cholesterol feeding decreased the sensitivity to acetylcholine, and treatment with fluvastatin significantly restored the diminished sensitivity to acetylcholine in thoracic aortae. Cholesterol feeding caused oxidatively induced DNA damage in liver tissues determined by the increased levels of 8‐hydroxyguanine (8‐OH‐Gua) and 2,6‐diamino‐4‐hydroxy‐5‐formamidopyrimidine (FapyGua). Fluvastatin decreased only FapyGua level in liver. In conclusion, our results may suggest that fluvastatin seems to play a protective role on high cholesterol‐induced oxidative stress and DNA damage. Copyright © 2012 John Wiley & Sons, Ltd.

[1]  M. Bennett,et al.  Role of DNA damage in atherosclerosis--bystander or participant? , 2011, Biochemical pharmacology.

[2]  J. Redón,et al.  Different Impacts of Cardiovascular Risk Factors on Oxidative Stress , 2011, International journal of molecular sciences.

[3]  Robert W Sobol,et al.  Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage. , 2011, Antioxidants & redox signaling.

[4]  Christos G Mihos,et al.  The Pleiotropic Effects of the Hydroxy-Methyl-Glutaryl-CoA Reductase Inhibitors in Cardiovascular Disease: A Comprehensive Review , 2010, Cardiology in review.

[5]  Kunihiro Suzuki,et al.  Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin. , 2010, International journal of cardiology.

[6]  J. Liao,et al.  Pleiotropic effects of statins. - Basic research and clinical perspectives -. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[7]  M. Dizdaroglu,et al.  Glutathione depletion by buthionine sulfoximine induces oxidative damage to DNA in organs of rabbits in vivo. , 2009, Biochemistry.

[8]  Zhaoqian Liu,et al.  Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits. , 2008, Nutrition.

[9]  T. Littlewood,et al.  Statins Use a Novel Nijmegen Breakage Syndrome-1–Dependent Pathway to Accelerate DNA Repair in Vascular Smooth Muscle Cells , 2008, Circulation research.

[10]  J. Fildes,et al.  Pleiotropic Effects and Cholesterol-Lowering Therapy , 2008, Cardiology.

[11]  T. Ajith,et al.  IN VITRO ANTI‐OXIDANT AND DNA PROTECTIVE EFFECTS OF THE NOVEL 3‐HYDROXY‐3‐METHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR ROSUVASTATIN , 2008, Clinical and experimental pharmacology & physiology.

[12]  M. Bennett,et al.  DNA damage and repair in atherosclerosis. , 2006, Cardiovascular research.

[13]  J. Beckman,et al.  The nonlipid effects of statins on endothelial function. , 2006, Trends in cardiovascular medicine.

[14]  M. Andreassi,et al.  Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. , 2005, Mutation research.

[15]  M. Evans,et al.  Oxidative DNA damage and disease: induction, repair and significance. , 2004, Mutation research.

[16]  K. Egashira,et al.  HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits. , 2003, Pharmacological research.

[17]  Teruo Inoue,et al.  Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia. , 2003, International journal of cardiology.

[18]  H. Mitani,et al.  Preservation of Endothelium‐Dependent and Nω‐Nitro‐L‐Arginine Methyl Ester‐ and Indomethacin‐Resistant Arterial Relaxation in High‐Cholesterol‐Diet Fed Rabbits by Treatment with Fluvastatin, an HMG‐CoA Reductase Inhibitor , 2003, Journal of cardiovascular pharmacology.

[19]  Ç. Ulukuş,et al.  Neuroprotective Effect of Erythropoietin on Hypoxic-Ischemic Brain Injury in Neonatal Rats , 2003, Neonatology.

[20]  Teruo Inoue,et al.  Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients. , 2002, Atherosclerosis.

[21]  G. D. De Meyer,et al.  Oxidative DNA Damage and Repair in Experimental Atherosclerosis Are Reversed by Dietary Lipid Lowering , 2001, Circulation research.

[22]  M. Dizdaroglu,et al.  Identification and quantification of 8,5'-cyclo-2'-deoxy-adenosine in DNA by liquid chromatography/ mass spectrometry. , 2001, Free radical biology & medicine.

[23]  M. Yasuhara,et al.  Fluvastatin, an HMG-CoA reductase inhibitor, protects LDL from oxidative modification in hypercholesterolemic rabbits. , 2000, Biological & pharmaceutical bulletin.

[24]  T. Onat,et al.  Antioxidant Enzyme Activities and Total Nitrite/ Nitrate Levels in the Collar Model. Effect of Nicardipine , 2000, Clinical chemistry and laboratory medicine.

[25]  M. Yasuhara,et al.  Superoxide anion scavenging properties of fluvastatin and its metabolites. , 1999, Chemical & pharmaceutical bulletin.

[26]  A. Sevanian,et al.  Cholesterol oxidation products induce vascular foam cell lesion formation in hypercholesterolemic New Zealand white rabbits. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[27]  K. Prasad,et al.  Prevention of Hypercholesterolemic Atherosclerosis by Garlic, an Antioxidant , 1997, Journal of cardiovascular pharmacology and therapeutics.

[28]  D. Erdinçler,et al.  Lipid peroxidation and antioxidant status in experimental animals: effects of aging and hypercholesterolemic diet. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[29]  A. Chobanian,et al.  Effects of hypertension on hypercholesterolemia-induced changes in contraction of rabbit aorta and carotid artery. , 1996, European journal of pharmacology.

[30]  K. Prasad,et al.  Effects of probucol on hypercholesterolemia-induced changes in antioxidant enzymes. , 1996, Life sciences.

[31]  P. Moriel,et al.  Plasma antioxidant enzymes and oxidized lipoproteins in hypercholesterolemic rabbits. , 1995, Biochemistry and molecular biology international.

[32]  A. Herman,et al.  Influence of chronic treatment with a nitric oxide donor on fatty streak development and reactivity of the rabbit aorta , 1995, British journal of pharmacology.

[33]  K. Prasad,et al.  Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits. , 1993, Atherosclerosis.

[34]  A. Herman,et al.  Effect of Hypercholesterolemia on Vascular Reactivity in the Rabbit: I. Endothelium‐Dependent and Endothelium‐Independent Contractions and Relaxations in Isolated Arteries of Control and Hypercholesterolemic Rabbits , 1986, Circulation research.

[35]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[36]  Y. Akçay,et al.  The effect of melatonin on lipid peroxidation and nitrite/nitrate levels, and on superoxide dismutase and catalase activities in kainic acid-induced injury. , 2005, Cellular & molecular biology letters.

[37]  A. Uysal,et al.  Effects of the calcium channel blocker amlodipine on serum and aortic cholesterol, lipid peroxidation, antioxidant status and aortic histology in cholesterol-fed rabbits. , 2003, Journal of biomedical science.

[38]  T. Yamashita,et al.  Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. , 2001, Atherosclerosis.

[39]  Y. Kusumi,et al.  Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition. , 2000, Journal of cardiovascular pharmacology.